Bangladesh — Fishery/Seafood Products — Fish-Other

← back to leaderboard

Bangladesh received 14 FDA import refusals in Fish-Other, part of Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 3 in 2024-Q1, with the trend rising sharply year-on-year. The most-cited issues are salmonella, usual name, and imptrhaccp. No trade baseline is published for this commodity from Bangladesh, so no per-$1B rate is shown here.

Of these, 13 were hazard refusals and 1 were paperwork refusals.

Exporting from Bangladesh? Get an email when shipments from Bangladesh are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q4 2023-Q4: 0 3 2024-Q1 2024-Q1: 3 3 2024-Q2 2024-Q2: 3 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 1 2025-Q1 2025-Q1: 1 0 2025-Q2 2025-Q2: 0 0 2025-Q3 2025-Q3: 0 1 2025-Q4 2025-Q4: 1 2 2026-Q1 2026-Q1: 2 3 2026-Q2 2026-Q2: 3 1 2026-Q3 2026-Q3: 1

Recent rejections